{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:22:24Z","timestamp":1782962544483,"version":"3.54.5"},"reference-count":26,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.3892\/or.2013.2328","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T13:25:22Z","timestamp":1362489922000},"page":"1867-1872","source":"Crossref","is-referenced-by-count":34,"title":["Core binding factor acute myeloid leukaemia and c-KIT mutations"],"prefix":"10.3892","volume":"29","author":[{"given":"LUDOVICA","family":"RIERA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FILIPPO","family":"MARMONT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIELA","family":"TOPPINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHIARA","family":"FRAIRIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANCESCA","family":"SISMONDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERNESTA","family":"AUDISIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CRISTIANA","family":"DI BELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEFANO","family":"D\u2019ARDIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAOLA FRANCIA","family":"DI CELLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMANUELA","family":"MESSA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIORGIO","family":"INGHIRAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UMBERTO","family":"VITOLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ACHILLE","family":"PICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"key20180107214242_b1-or-29-05-1867","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc840","article-title":"Core-binding factors in haematopoiesis and leukaemia","volume":"2","author":"Speck","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107214242_b2-or-29-05-1867","first-page":"110","article-title":"Acute myeloid leukaemia with recurrent genetic abnormalities","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Arber","year":"2008","edition":"4th edition"},{"key":"key20180107214242_b3-or-29-05-1867","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood.V90.11.4532","article-title":"Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a Cancer and Leukemia Group B Study","volume":"90","author":"Mr\u00f3zek","year":"1997","journal-title":"Blood"},{"key":"key20180107214242_b4-or-29-05-1867","first-page":"4173","article-title":"Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype","volume":"58","author":"Bloomfield","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107214242_b5-or-29-05-1867","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"key20180107214242_b6-or-29-05-1867","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107214242_b7-or-29-05-1867","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.leukres.2011.06.003","article-title":"Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia","volume":"35","author":"Park","year":"2011","journal-title":"Leuk Res"},{"key":"key20180107214242_b8-or-29-05-1867","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood.V90.4.1643","article-title":"Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)","volume":"90","author":"Baer","year":"1997","journal-title":"Blood"},{"key":"key20180107214242_b9-or-29-05-1867","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood-2002-11-3527","article-title":"Prognosis of inv(16)\/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup","volume":"102","author":"Delaunay","year":"2003","journal-title":"Blood"},{"key":"key20180107214242_b10-or-29-05-1867","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2004.03.012","article-title":"Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup","volume":"22","author":"Schlenk","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180107214242_b11-or-29-05-1867","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2005.15.610","article-title":"Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study","volume":"23","author":"Marcucci","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107214242_b12-or-29-05-1867","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1080\/10428190903085951","article-title":"Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome","volume":"50","author":"Markov\u00e1","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"key20180107214242_b13-or-29-05-1867","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0002-9440(10)64623-8","article-title":"Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases","volume":"157","author":"Lasota","year":"2000","journal-title":"Am J Pathol"},{"key":"key20180107214242_b14-or-29-05-1867","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107214242_b15-or-29-05-1867","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1158\/1078-0432.CCR-06-1745","article-title":"c-Kit\/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors","volume":"13","author":"Miselli","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107214242_b16-or-29-05-1867","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2141.2003.04500.x","article-title":"Flt3 mutations and leukaemia","volume":"122","author":"Kottaridis","year":"2003","journal-title":"Br J Haematol"},{"key":"key20180107214242_b17-or-29-05-1867","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood-2005-08-3167","article-title":"Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)","volume":"107","author":"Thiede","year":"2006","journal-title":"Blood"},{"key":"key20180107214242_b18-or-29-05-1867","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1182\/blood-2005-05-2168","article-title":"Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance","volume":"106","author":"Verhaak","year":"2005","journal-title":"Blood"},{"key":"key20180107214242_b19-or-29-05-1867","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2353\/jmoldx.2010.090054","article-title":"Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia (Review)","volume":"12","author":"Gulley","year":"2010","journal-title":"J Mol Diagn"},{"key":"key20180107214242_b20-or-29-05-1867","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.5858\/arpa.2010-0482-RS","article-title":"Core-binding factor acute myeloid leukemia","volume":"135","author":"Sangle","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107214242_b21-or-29-05-1867","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2006.06276.x","article-title":"The clinical spectrum of adult acute myeloid leukaemia associated with corebinding factor translocations","volume":"135","author":"Appelbaum","year":"2006","journal-title":"Br J Haematol"},{"key":"key20180107214242_b22-or-29-05-1867","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood-2002-02-0532","article-title":"Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial","volume":"101","author":"Kern","year":"2003","journal-title":"Blood"},{"key":"key20180107214242_b23-or-29-05-1867","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2403963","article-title":"Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)","volume":"19","author":"Germing","year":"2005","journal-title":"Leukemia"},{"key":"key20180107214242_b24-or-29-05-1867","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"key20180107214242_b25-or-29-05-1867","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404188","article-title":"Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)","volume":"20","author":"Boissel","year":"2006","journal-title":"Leukemia"},{"key":"key20180107214242_b26-or-29-05-1867","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOH.0b013e3283257b18","article-title":"Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?","volume":"16","author":"Dombret","year":"2009","journal-title":"Curr Opin Hematol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2328\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T06:09:25Z","timestamp":1595484565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,3,5]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.3892\/or.2013.2328"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2328","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}